Podcast

Investigative journalist and author Violet Blue discusses the COVID Safety Handbook. Also, the latest COVID-19 numbers, and looking at longer Paxlovid courses.

In the last episode of 2024, recapping freelancer Hannah Buttle’s reporting on how the treatment landscape for Long COVID has pushed some to look to online drug markets. Also in this episode: the latest COVID-19 numbers, and more research funding, plus some podcast stats.

This week, playwright and rock musician Dan Fishback talks about his new production about living with ME/CFS in a pandemic. Also in this episode: the latest COVID-19 numbers, a randomized, controlled clinical trial looking at the monoclonal antibody Evusheld 2.0, and Mt. Sinai’s Cohen Center for Recovery from Complex Chronic Illness (CoRE) looks for new…

This week, co-host Betsy Ladyzhets talks with producer James Salanga about what the potential Long COVID research landscape could look like under Trump.

This week, reporter Simon Spichak talks about his coverage of the lack of pediatric clinical trials for Long COVID. Also in this episode: the latest COVID-19 numbers, results from the BC 007 clinical trial, and REVERSE-LC begins recruitment.

This week, we celebrate one year of The Sick Times! Also in this episode: the latest COVID-19 numbers, and recapping the team’s coverage of the Fall 2024 PolyBio Symposium on Long COVID Research.

This week, oral histories from mask bloc organizers are interspersed with some context from journalist and author Britta Shoot, who put together a three-part series collaging said oral histories.

This week, oral histories from mask bloc organizers are interspersed with some context from journalist and author Britta Shoot, who put together a three-part series collaging said oral histories.

This week, co-hosts Betsy Ladyzhets and Miles Griffis talk with podcast producer James Salanga about an Australian clinical trial looking at low-dose naltrexone for people living with Long COVID and ME.